tiprankstipranks
Trending News
More News >
Enveric Biosciences (DE:SLZA)
FRANKFURT:SLZA
Germany Market

Enveric Biosciences (SLZA) Income Statement

Compare
1 Followers

Enveric Biosciences Income Statement

Last quarter (Q3 2024), Enveric Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Enveric Biosciences's net income was $-2.08M. See Enveric Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ 39.91M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 343.98K$ 327.91K$ 656.64K$ 120.87K$ 2.27M
EBITDA
$ -17.89M$ -19.52M$ -55.74M$ -6.30M$ -2.21M
Operating Income
$ -16.45M$ -27.42M$ -64.62M$ -5.62M$ -2.30M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -17.31M$ -18.50M$ -48.98M$ -6.86M$ -2.35M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Enveric Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis